Bank Of Montreal »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Bank Of Montreal

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Bank Of Montreal from 13F filings

Historical chart of Bank Of Montreal investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Bank Of Montreal consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Bank Of Montreal

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 14M 0.93
2023-09-30 $3.6M 3.7M 0.96

More positions owned by Bank Of Montreal

Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Apple (AAPL)
Tesla Motors (TSLA)
Rbc Cad (RY)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Toronto Dominion Bk Ont Com New (TD)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Bk Nova Cad (BNS)
Meta Platforms Cl A (META)
Cibc Cad (CM)
Bank Of Montreal Cadcom (BMO)
Walt Disney Company (DIS)

View all positions for Bank Of Montreal

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Citadel Advisors
Polar Securities
Millennium Management
Bank Of Montreal
Kohlberg Kravis Roberts & Co
D. E. Shaw & Co
Absolute Investment Advisers
Leucadia National Corporation
SSI Investment Management
CSS
Readystate Asset Management

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1